Saturday 17 October 2026
Export JYNT’s income statement to Excel — free account
The Joint Corp.
JYNT Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 14.4%, EPS grew 400.0% and free cash flow grew 432.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.03
0.12
+1.74%
Follow JYNT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
32.52 | 38.48 | 45.89 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.14 | 2.22 | 2.40 | 2.69 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
57.05 | (85.02) | 45.55 | 82.57 | |
P/B ratio |
7.88 | 8.10 | 8.75 | 6.44 | |
Price to Tangible BV |
10.75 | 11.15 | 12.17 | 7.92 | |
EV/Sales |
1.78 | 1.87 | 2.00 | 2.16 | |
EV/EBITDA |
33.11 | 44.79 | 137.04 | 120.11 | |
EV/Operating CF |
19.32 | 26.11 | 59.66 | 38.32 | |
EV/FCF |
(99.45) | (40.51) | (22.20) | (32.31) | |
Quick Ratio |
1.06 | 0.79 | 0.83 | 1.02 | |
Current Ratio |
1.83 | 1.64 | 1.59 | 1.83 | |
Net Debt/EBITDA |
(411.51) | (16.76) | (20.50) | (49.22) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.94 | 0.82 | 0.76 | 0.73 | |
Operating CF/Net income |
3.36 | (1.14) | 2.92 | 2.07 | |
Capex/Depreciation |
(0.60) | (0.58) | (0.79) | (0.69) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
81.96% | 72.89% | 73.65% | 75.57% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.79% | 1.89% | 2.15% | 2.59% | |
Graham Net Nets |
0.06 | 0.06 | 0.05 | 0.09 | |
Graham Number |
2.60 | 2.38 | 2.06 | 0.00 | |
Earnings Yield |
3.08% | 2.60% | 2.18% | (0.63%) | |
Free Cash Flow Yield |
(0.84%) | (2.09%) | (3.74%) | (2.49%) | |
Revenue per Share |
1.07 | 1.05 | 1.00 | 0.87 | |
Operating CF per Share |
0.15 | (0.10) | 0.19 | 0.12 | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Free Cash Flow per Share |
0.14 | (0.12) | 0.17 | 0.09 | |
Cash per Share |
1.61 | 1.51 | 1.61 | 2.00 | |
Shareholders Equity per Share |
1.11 | 1.09 | 1.00 | 1.48 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.11 | 1.09 | 1.00 | 1.48 | |
Free Cash Flow |
1.94 | (1.71) | 2.55 | 1.46 | |
Working Capital |
19.82 | 19.42 | 19.27 | 27.45 | |
Capital Expenditures |
(0.26) | (0.23) | (0.35) | (0.32) | |
Net Current Asset Value |
8.05 | 7.16 | 6.20 | 13.84 | |
EV/EBIT |
73.91 | 166.08 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Price to Operating Income |
88.81 | 196.47 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.60 | 2.66 | 2.72 | 3.60 | |
Average Payables |
1.34 | 0.99 | 1.67 | 1.55 | |
Average Assets |
62.41 | 69.01 | 72.06 | 74.49 | |
Average Common Equity |
19.57 | 19.17 | 17.88 | 21.60 |
Columns are period end dates